Company
Cochlear
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
20
510(k), De Novo and PMA
Device trials
92
As lead sponsor, any status
Adverse event reports
4,388
Received Nov 1, 2025 to Nov 19, 2026
Recall records
6
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Cochlear, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Cochlear.
Latest FDA decisions
The 8 newest of 20 since 2015.
K260902 · Decided Jul 10, 2026 · 114 days after receipt
Device type: Active Implantable Bone Conduction Hearing System (PFO) · Otolaryngology (ENT)
K250215 · Decided May 29, 2025 · 125 days after receipt
Device type: Hearing Aid, Bone Conduction (LXB) · Otolaryngology (ENT)
- Cochlear Osia System510(k)
K240155 · Decided Apr 18, 2024 · 90 days after receipt
Device type: Active Implantable Bone Conduction Hearing System (PFO) · Otolaryngology (ENT)
- Instrument Case510(k)
K231604 · Decided Aug 24, 2023 · 84 days after receipt
Device type: Sterilization Wrap Containers, Trays, Cassettes & Other Accessories (KCT) · Hospital Medicine & Nursing
K231204 · Decided Aug 18, 2023 · 113 days after receipt
Device type: Active Implantable Bone Conduction Hearing System (PFO) · Otolaryngology (ENT)
- Instrument Case P1340904510(k)
K223672 · Decided Mar 21, 2023 · 104 days after receipt
Device type: Sterilization Wrap Containers, Trays, Cassettes & Other Accessories (KCT) · Hospital Medicine & Nursing
K220922 · Decided Jul 27, 2022 · 118 days after receipt
Device type: Active Implantable Bone Conduction Hearing System (PFO) · Otolaryngology (ENT)
- Nucleus 24 Cochlear Implant SystemPMA supplement
P970051-S205 · Decided Jan 10, 2022 · 227 days after receipt · Panel Track
Device type: Implant, cochlear (MCM) · Otolaryngology (ENT)
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Effect of a Totally Implantable Cochlear Implant on Tinnitus Severity in Adults With Preoperative TinnitusNot yet recruiting
NCT07893860 · 14 participants (planned) · Start Feb 2027 · Primary completion Apr 2028
Device: Cochlear implant · For: Sensorineural Hearing Loss; Tinnitus
Sites: Las Palmas de Gran Canaria, Spain
- An Investigation to Evaluate Sound Coding Enhancements in Adult Cochlear Implant RecipientsActive, not recruiting
NCT06867380 · 120 participants (planned) · Start May 27, 2025 · Primary completion Apr 2030
Device: Investigational sound coding strategy A; Cochlear default sound coding strategy A and 2 more · For: Cochlear Implant Recipients; Hearing Loss, Cochlear
Sites: Carlton, Australia; East Melbourne, Australia
- A Study to Evaluate Clinical Benefit, Performance and Safety of Cochlear Implants in AdultsNot yet recruiting
NCT07338864 · 66 participants (planned) · Start Dec 2026 · Primary completion May 2028
Device: Cochlear Nucleus Nexa Cochlear implant (CI1032); Cochlear Nucleus Nexa Cochlear implant (CI1022) and 1 more · For: Hearing Loss; Hearing Implants
Sites: Düsseldorf, Germany
- An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research AppActive, not recruiting
NCT06098482 · 46 participants (planned) · Start Feb 5, 2024 · Primary completion May 2, 2027
Device: Mobile Research App (MRA) · For: Hearing Loss
Sites: Lone Tree, Colorado; Melbourne, Australia; Antwerp, Belgium · 4 sites in all
NCT02379273 · 35 participants · Start Jan 14, 2015 · Primary completion Mar 18, 2019
Device: Nucleus Hybrid L24 Implant · For: Hearing Loss
NCT07582198 · 26 participants · Start May 20, 2026 · Primary completion Sep 24, 2026
Device: Nucleus 7 Sound Processor; Nucleus 8 Sound Processor · For: Hearing Loss
Sites: Lone Tree, Colorado
Reports received
4,388
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
414
9.4% of reports
Injury reports
3,973
91% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 20 | 308 | 0 | 0 |
| Jan 24 | 33 | 308 | 0 | 0 |
| Feb 24 | 47 | 257 | 0 | 0 |
| Mar 24 | 43 | 328 | 0 | 0 |
| Apr 24 | 33 | 338 | 0 | 0 |
| May 24 | 42 | 339 | 0 | 0 |
| Jun 24 | 32 | 273 | 0 | 0 |
| Jul 24 | 34 | 314 | 2 | 0 |
| Aug 24 | 33 | 260 | 0 | 0 |
| Sep 24 | 36 | 304 | 1 | 0 |
| Oct 24 | 39 | 326 | 0 | 0 |
| Nov 24 | 49 | 294 | 0 | 0 |
| Dec 24 | 37 | 311 | 0 | 0 |
| Jan 25 | 31 | 284 | 0 | 0 |
| Feb 25 | 37 | 335 | 0 | 0 |
| Mar 25 | 32 | 295 | 1 | 0 |
| Apr 25 | 34 | 398 | 0 | 0 |
| May 25 | 43 | 332 | 0 | 0 |
| Jun 25 | 26 | 308 | 0 | 0 |
| Jul 25 | 46 | 302 | 0 | 0 |
| Aug 25 | 22 | 319 | 0 | 0 |
| Sep 25 | 32 | 366 | 0 | 0 |
| Oct 25 | 49 | 345 | 0 | 0 |
| Nov 25 | 44 | 329 | 0 | 0 |
| Dec 25 | 36 | 310 | 0 | 0 |
| Jan 26 | 38 | 326 | 0 | 0 |
| Feb 26 | 30 | 338 | 0 | 0 |
| Mar 26 | 31 | 352 | 0 | 0 |
| Apr 26 | 36 | 392 | 0 | 0 |
| May 26 | 30 | 315 | 0 | 0 |
| Jun 26 | 28 | 313 | 0 | 0 |
| Jul 26 | 50 | 367 | 0 | 0 |
| Aug 26 | 23 | 242 | 0 | 1 |
| Sep 26 | 37 | 376 | 0 | 0 |
| Oct 26 | 31 | 313 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- ASKU199
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0349-2027 · Started Sep 30, 2026 · Posted by FDA Nov 3, 2026
Reason given: Due to a manufacturing deviation of incomplete electrode welds of cochlear implants and resulting in one or more open circuits
Cause as FDA categorized it: Under Investigation by firm · Device type: Implant, Cochlear (MCM)
Z-0792-2020 · Started Dec 18, 2018
Reason given: Product was packaged with the Incorrect tamper proof battery door.
Cause as FDA categorized it: Packaging process control · Device type: Hearing Aid, Bone Conduction (LXB)
Z-2155-2015 · Started Jun 5, 2015 · Posted by FDA Jul 20, 2015
Reason given: Cochlear Americas is recalling Nucleus Sterile Silicone Template CI24RE/CI422 part number Z421736 because expired product was distributed.
Cause as FDA categorized it: Process control · Device type: Implant, Cochlear (MCM)
Z-1699-2014 · Started Apr 9, 2014 · Posted by FDA Jun 2, 2014
Reason given: Cochlear America is recalling Cochlear Baha Soft Tissue Gauge due to possible manufacturing imperfection in the smooth surface of the metal that could potentially leave residual metal on the patient's skin.
Cause as FDA categorized it: Process control · Device type: Hearing Aid, Bone Conduction (LXB)
Z-0003-2012 · Started Sep 16, 2011 · Posted by FDA Oct 3, 2011
Reason given: Cochlear implant may shut down and cease to function.
Cause as FDA categorized it: Component design/selection · Device type: Implant, Cochlear (MCM)
- Nucleus Non-Magnetic Plug for removable magnet implants, REF Z50100, STERILE EO, Cochlear Limited.Terminated
Z-0119-2010 · Started Sep 30, 2009 · Posted by FDA Nov 2, 2009
Reason given: Cochlear implant device component was mis-labeled.
Cause as FDA categorized it: Labeling mix-ups · Device type: Implant, Cochlear (MCM)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.